Methylenedioxyphentermine

Methylenedioxyphentermine
Identifiers
CAS number 39235-63-7
Jmol-3D images Image 1
Properties
Molecular formula C11H15NO2
Molar mass 193.24
 YesY (verify) (what is: YesY/N?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

3,4-Methylenedioxyphentermine (MDPH) is a lesser-known psychedelic drug. MDPH was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the dosage range is listed as 160-240 mg, and the duration as 3–5 hours. MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.

See also

References

External links


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Chlorphentermine — Systematic (IUPAC) name 1 (4 chlorophenyl) 2 methylpropan 2 amine Clinical data Pregnancy cat.  ? …   Wikipedia

  • Clortermine — Systematic (IUPAC) name 1 (2 chlorophenyl) 2 methylpropan 2 amine Clinical data Pregnancy cat.  ? …   Wikipedia

  • MDPH — Chembox new ImageFile = MDPH.png ImageSize = 200px IUPACName = 2 Benzo [1,3] dioxol 5 yl 1,1 dimethyl ethylamine OtherNames = 3,4 Methylenedioxyphentermine; 3,4 Methylenedioxy alpha,alpha dimethyl 1 ethane Section1 = Chembox Identifiers CASNo =… …   Wikipedia

  • Substituted methylenedioxyphenethylamines — Methylenedioxyphenethylamine (MDPEA) Substituted methylenedioxy phenethylamines (MDxx) make up a large chemical class of derivatives of the phenethylamines, which includes many psychoactive drugs that act as entactogens, psychedelics, and/or …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.